z-logo
open-access-imgOpen Access
Apaf1 inhibition promotes cell recovery from apoptosis
Author(s) -
Anna Gortat,
Mónica Sancho,
Laura Mondragón,
Ángel Messeguer,
Enríque PérezPayá,
Mar Orzáez
Publication year - 2015
Publication title -
protein and cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.973
H-Index - 63
eISSN - 1674-8018
pISSN - 1674-800X
DOI - 10.1007/s13238-015-0200-2
Subject(s) - apoptosome , apoptosis , microbiology and biotechnology , intrinsic apoptosis , cytochrome c , programmed cell death , biology , cell sorting , mitochondrion , cell , caspase , chemistry , biochemistry
The protein apoptotic protease activating factor 1 (Apaf1) is the central component of the apoptosome, a multiprotein complex that activates procaspase-9 after cytochrome c release from the mitochondria in the intrinsic pathway of apoptosis. We have developed a vital method that allows fluorescence-activated cell sorting of cells at different stages of the apoptotic pathway and demonstrated that upon pharmacological inhibition of Apaf1, cells recover from doxorubicin- or hypoxia-induced early apoptosis to normal healthy cell. Inhibiting Apaf1 not only prevents procaspase-9 activation but delays massive mitochondrial damage allowing cell recovery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom